Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia [Phase 3]
A Phase 3 study evaluating the safety and efficacy of clozapine in treatment-resistant schizophrenia has completed, sponsored by Novartis.
-
FDA approval · 2016-04-19FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approves a supplemental application for thioridazine hydrochloride (generic) submitted by Chartwell RX, LLC.
-
FDA approval · 2016-04-19FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride, with Chartwell RX, LLC as the sponsor.
-
FDA approval · 2016-04-19FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride by Chartwell RX, LLC under ANDA 088134.
-
FDA approval · 2016-04-19FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride (Chartwell RX, LLC). This is a routine regulatory action on an approv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Cognitive Rehabilitation in Schizophrenia [NA]
A completed clinical trial evaluating cognitive rehabilitation in schizophrenia, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia [Phase 4]
A Phase 4 trial evaluating the effects of paliperidone extended-release versus risperidone immediate-release on cognitive function in clinic…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Integrated Coping and Awareness Training [NA]
This clinical trial update reports the completed study of Integrated Coping and Awareness Training for schizophrenia, sponsored by the Unive…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetics study of single doses of APN1125 in healthy normal subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia [Phase 4]
Phase 4 clinical trial evaluating omega-3 fatty acids (Lovaza) for hypertriglyceridemia associated with second-generation antipsychotics. Re…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: DAAOI-1 Treatment for Treatment-resistant Schizophrenia [Phase 2]
A Phase 2 clinical trial of DAAOI-1 for treatment-resistant schizophrenia has completed.
-
FDA approval · 2016-03-29FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
The FDA approved a supplemental application for FANAPT (iloperidone) submitted by Vanda Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia [Phase 3]
This document reports the completion and posting of results for a Phase 3 monotherapy trial of brexpiprazole in adults with early-episode sc…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Brexpiprazole in Patients With Acute Schizophrenia [Phase 3]
Phase 3 trial evaluating brexpiprazole in patients with acute schizophrenia has completed and results were posted.
-
EMA withdrawal · 2016-03-29EMA Application withdrawn: Aripiprazole Mylan (aripiprazole) — Mylan S.A.S.
The EMA withdrew the application for Aripiprazole Mylan (aripiprazole) by Mylan S.A.S. for schizophrenia.
-
FDA label_change · 2016-03-29FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
The FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc., resulting in a…
-
FDA approval · 2016-03-24FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) from Alkermes, Inc.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers [Phase 1]
Phase 1 comparative bioavailability study evaluating a 10 mg aripiprazole oral soluble film against the 10 mg Abilify tablet in healthy volu…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Can we Forget? Directed Forgetting and Embodied Cognition in Schizophrenia [NA]
This completed clinical trial examined directed forgetting and embodied cognition in people with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of once-weekly zicronapine in adults with schizophrenia has…
-
CLINICAL_TRIALS research · 2016-03-22Clinical Trial Update: Psychoeducation for Vietnamese Families With a Patient With Schizophrenia [NA]
Clinical trial update noting the completion of a study on psychoeducation for Vietnamese families of a patient with schizophrenia. The study…
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Antipsychotic Augmentation With L-Dopa [Phase 2]
Phase 2 trial assessing augmentation of an antipsychotic with L-Dopa in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia [Phase 4]
A Phase 4 safety and effectiveness study of paliperidone palmitate in Chinese patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine [Phase 4]
Phase 4 clinical trial comparing olanzapine alone to low-dose olanzapine plus trifluoperazine for schizophrenia has completed.
-
CLINICAL_TRIALS research · 2016-03-10Clinical Trial Update: Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)
This document reports a completed longitudinal registry (PEARL) evaluating the effectiveness of Paliperidone Palmitate in schizophrenia. The…